Sunday, May 28, 2017
Company News: Page (1) of 1 - 03/17/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Equitas Health Commemorates the 30th Anniversary of First Treatment for AIDS - AZT
(March 17, 2017)

COLUMBUS, Ohio, March 17, 2017 /PRNewswire-USNewswire/ -- In recognition of the 30th anniversary of the first AIDS drug AZT, Equitas Health looks at the impact of AZT, the current state of HIV, and hopes for the future.

The early years of the AIDS epidemic were an incredibly challenging time as researchers and doctors struggled to understand the virus, how it was being spread, how to detect it, and how to intervene.  "AZT was a critical first step it offered hope to patients for the first time, it spurred HIV drug development, and the world began to see AIDS as a treatable disease," said Dr. Herchline, Infectious Disease Physician at Equitas Health.

In 1996, the introduction of the "AIDS cocktail", a triple combination therapy with AZT, another drug of its class, and a protese inhibitor, gave patients and doctors new hope. "Now you take one pill a day with three drugs in it; it stops the virus from multiplying, your body heals, and you have a normal life expectancy," said Dr. Herchline.

Despite remarkable advances in drug therapy and testing services, 1 in 5 people are HIV-positive but don't know it. If current rates continue, 1 in 6 gay and bisexual men will be diagnosed with HIV in their lifetime, with men of color disproportionately impacted.  "Thanks to our integrated patient-centered care model, 92% of our HIV positive patients are engaged in an anti-retroviral drug regimen, compared to 37% nationally. Our viral suppression rate, meaning those individuals who are HIV-positive and living with such low levels of HIV in their body they are not able to transmit the disease, is 87% compared to 30% nationally," said Bill Hardy, President & CEO of Equitas Health.

While there has been tremendous progress, an HIV-positive diagnosis remains a challenging diagnosis for many. "Today, treatment still requires indefinite, sometimes costly, daily medication and potential side effects. In the near future, there may be alternative treatments available and someday, hopefully, a cure. In the meantime, Equitas Health remains committed to providing a welcoming healthcare home for those at-risk or infected with HIV/AIDS," said Dr. Herchline.


Equitas Health (formerly AIDS Resource Center Ohio) is a not-for-profit community-based healthcare system founded in 1984. Its expanded mission has made it one of the nation's largest HIV/AIDS, lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ) healthcare organizations. For more information, visit

CONTACT: Alyssa Chenault, (614) 526-4161


To view the original version on PR Newswire, visit:

SOURCE Equitas Health

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Medicine, Disease, Sexual, healthcare, Surgery, Medication, Physician, Science, Medical, Medical Professionals, Men,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
  • Medical Imaging Equipment Market Is Expected To Reach USD 44,887.4 Mn By 2022, Credence Research
  • Growth Opportunities in the Global Diagnostic Imaging Market, 2017-2022 - Research and Markets

  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines